Editorial: Taking the Next Step Towards Validating Social Processes From the Research Domain Criteria - 27/10/20
, Benjamin E. Yerys, PhD bRésumé |
Navigating social interactions and relationships is a complex endeavor. The successful management of these activities calls upon a variety of underlying biological and behavioral mechanisms that are contextualized by environmental demands. Social challenges can arise for many different reasons, but autism spectrum disorder (ASD) is the prototypical disorder of social behavior. That being stated, clinically significant interference with social functioning is shared across a variety of neurodevelopmental and psychiatric conditions. Recognition of the cross-cutting nature of social impairments and deficits in other domains (eg, Cognitive Systemds and Sensorimotor Systems) led to the formation of the Research Domain Criteria (RDoC) initiative from the National Institute of Mental Health (NIMH).1 RDoC was proposed as an alternative framework to studying psychiatric conditions. RDoC emphasizes enhancing knowledge on the nature of psychiatric conditions in terms of varying degrees of dysfunction across general biological and psychological systems irrespective of traditional psychiatric diagnoses. The RDoC domains were created through consensus agreement from content-area expert scientists. One such domain, Systems for Social Processes, inclues the following proposed constituent constructs: (1) Attachment and Affiliation; (2) Social Communication (subdivided into Production of Facial Communication and Production of Non-Facial Communication); and (3) Perception and Understanding of Mental States. However, this domain has yet to be formally validated.
Le texte complet de cet article est disponible en PDF.| Dr. Wallace was supported by funding from the National Institute of Mental Health (R01MH100028) and internal funding from The George Washington University. Dr. Yerys was supported by funding from the National Institute of Mental Health (R01MH117807; R01HD096221; R01MH107431), the Eagles Autism Challenge, Inc., Aevi Genomic Medicine, Zelda Therapeutics, and F. Hoffman-La Roche Ltd. |
|
| Drs. Wallace and Yerys contributed equally to this work. |
|
| Author Contributions |
|
| Writing – original draft: Wallace, Yerys |
|
| Writing – review and editing: Wallace, Yerys |
|
| ORCID |
|
| Gregory L. Wallace, PhD: 0000-0003-0329-5054 |
|
| Benjamin E. Yerys, PhD: 0000-0002-7370-0740 |
|
| Disclosure: Dr. Wallace has received funding from the National Institute of Mental Health, the Healthy Weight Research Network, the Children’s National Health System/The George Washington University Clinical and Translational Sciences Institute, and internal funding from The George Washington University. Dr. Yerys has received research funding from the National Institute of Child and Human Development, the National Institute of Mental Health, Akili Interactive Labs Inc., Aevi Genomic Medicine, F. Hoffman-La Roche Ltd., the Allerton Foundation, the Eagles Autism Challenge, Inc., Zelda Therapeutics, and the McMorris Family Foundation, in the past two years. He has anticipated new funding from the Department of Defense in the next year. He has served as a consultant for Aevi Genomic Medicine, Boston Consulting Group, Clarion, Key Quest Health Ltd., and the Lancaster-Lebanon Intermediate Unit 13, in the past two years. All funding mentioned here is unrelated to the research in the present manuscript. |
|
| All statements expressed in this column are those of the authors and do not reflect the opinions of the Journal of the American Academy of Child and Adolescent Psychiatry. See the Instructions for Authors for information about the preparation and submission of Editorials. |
Vol 59 - N° 11
P. 1212-1214 - novembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
